Literature DB >> 2464098

Dihydropyridine binding sites in aerobically perfused, ischemic, and reperfused rat hearts: effect of temperature and time.

X H Gu1, J S Dillon, W G Nayler.   

Abstract

The time course of normothermic (37 degrees C) and hypothermic (22 degrees C) global ischemia, and of post-ischemic reperfusion on the affinity (KD), selectivity, and density (Bmax) of the high-affinity 1,4 dihydropyridine (DHP) calcium channel antagonist binding sites were studied in isolated rat heart membranes, using (+)[3H]PN 200-110. Short periods (10 or 20 min) of ischemia at either 37 degrees C or 22 degrees C altered neither the KD nor Bmax of these binding sites as compared with aerobic controls. By contrast, longer periods of normothermic ischemia (30 or 60 min) caused a reduction (p less than 0.05) in Bmax (36% after 30 min and 32.7% after 60 min) without change of KD. This reduction in Bmax was reversed by 15-min reperfusion at 37 degrees C after 30 but not 60-min ischemia. There was no effect of ischemia (up to 60 min) on the density of DHP binding sites under hypothermic conditions. Irrespective of the experimental conditions the selectivity of the binding sites was maintained, with (+)PN 200-100 greater than (-)Bay K8644 greater than (-)PN 200-110 = (+)Bay K8644 much greater than (-)D600 in displacing (+)[3H]PN 200-110, and D-cis diltiazem stimulating the binding. These results show that the ischemia-induced change in Bmax is specific, reversible, and time- and temperature-dependent.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2464098     DOI: 10.1097/00005344-198809000-00003

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  5 in total

1.  Streptozotocin-induced diabetes reduces the density of [125I]-endothelin-binding sites in rat cardiac membranes.

Authors:  W G Nayler; J J Liu; S Panagiotopoulos; D J Casley
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

Review 2.  Basic mechanisms involved in the protection of the ischaemic myocardium. The role of calcium antagonists.

Authors:  W G Nayler
Journal:  Drugs       Date:  1991       Impact factor: 9.546

3.  The failure of endothelin to displace bound, radioactively-labelled, calcium antagonists (PN 200/110, D888 and diltiazem).

Authors:  X H Gu; J J Liu; J S Dillon; W G Nayler
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

4.  Protection by verapamil and nifedipine against ischaemia-induced loss of [3H]-(+)-PN 200-110 binding sites in the rat heart.

Authors:  F T van Amsterdam; M S van Amsterdam-Magnoni; M Haas; N C Punt; J Zaagsma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990 Jan-Feb       Impact factor: 3.000

5.  Evidence for multiple endothelin receptors in the guinea-pig pulmonary artery and trachea.

Authors:  L O Cardell; R Uddman; L Edvinsson
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.